On Jan 5, 2022, NRx Pharmaceuticals announced that it had submitted an application for Emergency Use Authorization (EUA)…
On Dec. 16, 2021, NIH scientists announced that to counter future coronavirus outbreaks, the global scientific and medical…
On Oct. 18, 2021, the National Institutes of Health launched a program to study a rare type of…
On Oct. 14, 2021, The NIH Rapid Acceleration of Diagnostics (RADx) initiative announced that it has issued contract…
On Oct. 7, 2021, BD (Becton, Dickinson) announced it had strengthened the U.S. government’s access to safety injection…
On Oct. 6, 2021, the The NIH Brain Research through Advancing Innovative Neurotechnologiesï¾® (BRAIN?) Initiative Cell Census Network…
On Oct. 4, 2021, the Fred & Pamela Buffett Cancer Center announced it had successfully renewed its National…
This cartoon illustrates the various issues facing individuals across the U.S. who are vaccinated against COVID-19 verus those…
On Sept. 15, 2021, the National Institutes of Health (NIH) awarded nearly $470 million to build a national…
On Sept. 14, 2021, the NIH announced that an international project called the COVID Human Genetic Effort has…
On Sept. 9, 2021, the NIH announced that it was providing approximately $185 million over five years to…
On Sept. 6, 2021, a genomic analysis of lung cancer in people with no history of smoking has…
On Aug. 30, 2021, after 30 years of steady progress, National Institute of Allergy and Infectious Diseases (NIAID)…
On Aug. 30, 2021, Oragenics announced that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator…
On Aug. 16, 2021, scientists at the National Institutes of Health (NIH) announced they had developed a new…
On Aug. 13, 2021, Rigel Pharma announced that the U.S. Food and Drug Administration (FDA) had informed the…
On Aug. 11, 2021, the National Institutes of Health (NIH) announced that one dose of a new monoclonal…
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
On Jul. 30, 2021, Humanigen announced that the NIH had advanced the ACTIV-5/BET-B study to a Phase 2/3…
On Jul. 27, 2021, Oragenics announced it had entered into a licensing agreement with the National Research Council…
On Jul. 26, 2021, Trevena announced that the first COVID-19 patient had been enrolled in the NIH-funded ACTIV-4…
Planning a Summer vacation? Where to go? How about going to one of those large events with tens…
On Jul. 22, 2021, the National Institutes of Health announced it had renewed grants to seven regional centers…
On Jul. 8, 2021, the National Institutes of Health (NIH) announced that a new study authored by scientists…
On Jun. 30, 2021, the National Institutes of Health announced a highly anticipated study that compared rapid antigen…
On Jun. 29, 2021, Rigel Pharma announced that fostamatinib, the Company’s novel oral spleen tyrosine kinase (SYK) inhibitor,…
On Jun. 17, 2021, the Biden Administration is investing more than $3 billion to accelerate the discovery, development…
On Jun. 16, 2021, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that was recruiting volunteers in the…
On Jun. 3, 2021, the National Institutes of Health announced that the experimental drug TEMPOL may be a…
On Jun. 1, 2021, a first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle…